Improving decision-making for rheumatoid arthritis patients with cancer
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
This study is looking at how to help patients with rheumatoid arthritis and cancer make better treatment decisions together with their doctors, focusing on their worries about using certain medications, so they can feel more confident and safe in their choices.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11292534 on NIH RePORTER |
What this research studies
This research investigates how to enhance shared decision-making between healthcare providers and patients with rheumatoid arthritis (RA) who also have cancer. It aims to understand the concerns and experiences of these patients regarding the use of disease-modifying anti-rheumatic drugs (DMARDs), which are often avoided due to fears of worsening cancer outcomes. By employing a mixed methods approach, the study will gather both qualitative and quantitative data to inform treatment guidelines and improve patient care. The goal is to empower patients in their treatment choices while ensuring their safety and well-being.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with rheumatoid arthritis who also have a history of cancer or are currently undergoing cancer treatment.
Not a fit: Patients with rheumatoid arthritis who do not have a history of cancer or are not currently undergoing cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment options and improved health outcomes for patients with rheumatoid arthritis and cancer.
How similar studies have performed: Previous studies have shown that shared decision-making approaches can improve patient satisfaction and treatment adherence, suggesting potential success for this research.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Singh, Namrata — University of Washington
- Study coordinator: Singh, Namrata
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.